亿帆医药跌2.04%，成交额1.34亿元，主力资金净流出483.42万元

Company Overview - Yifan Pharmaceutical Co., Ltd. is located in Lin'an District, Hangzhou, Zhejiang Province, established on November 10, 2000, and listed on July 13, 2004 [1] - The company primarily engages in the production and sales of active pharmaceutical ingredients and high polymer materials, with revenue composition as follows: proprietary pharmaceutical products (including imports) 75.52%, vitamins 11.47%, other pharmaceutical products 9.52%, high polymer materials 3.00%, and pharmaceutical services 0.49% [1] Financial Performance - As of August 29, 2025, Yifan Pharmaceutical achieved a revenue of 2.635 billion yuan, representing a year-on-year growth of 0.11%, and a net profit attributable to shareholders of 304 million yuan, reflecting a year-on-year increase of 19.91% [2] - The company has distributed a total of 1.328 billion yuan in dividends since its A-share listing, with 243 million yuan distributed over the past three years [3] Stock Performance - On September 9, Yifan Pharmaceutical's stock price decreased by 2.04%, trading at 15.38 yuan per share, with a total market capitalization of 18.708 billion yuan [1] - Year-to-date, the stock price has increased by 44.82%, with a recent decline of 2.53% over the last five trading days, a 3.15% increase over the last 20 days, and a 10.97% increase over the last 60 days [1] Shareholder Information - As of August 29, 2025, the number of shareholders increased to 42,900, a rise of 3.38%, while the average circulating shares per person decreased by 3.27% to 19,634 shares [2] - As of June 30, 2025, Hong Kong Central Clearing Limited is the second-largest circulating shareholder, holding 25.5819 million shares, an increase of 2.4783 million shares from the previous period [3]